We have cloned the first glucose transporter CaHGT1 (Candida albicans high-affinity glucose transporter) of a pathogenic yeast, Candida albicans. The DNA sequence (GenBank accession number Y16834) analysis revealed an ORF encoding a novel protein of 545 amino acids with a predicted molecular mass of 60.67 kDa. The putative protein with 12 transmembrane domains has 51% identity with Kluyveromyces lactis high-affinity glucose transporter, HGT1. The protein signatures which are conserved and distinctive of the sugar transporters belonging to the major facilitator superfamily (MFS) were also found in CaHgt1p. When heterologously expressed, the ORF functionally complemented a mutant strain of Saccharomyces cerevisiae RE700A which was deleted in seven hexose transporter genes and thus was unable to grow or transport glucose. The expression of CaHGT1 in C. albicans showed a transcript of 1.6 kb which was enhanced in response to the human steroid hormone progesterone. Interestingly, the transcript levels were also enhanced in the presence of drugs, e.g. cycloheximide, chloramphenicol and benomyl. The results suggest that CaHGT1, which encodes a MFS protein, could be linked to the drug resistance phenomenon in C. albicans. ß
Introduction
Candida albicans is an opportunistic, infectious pathogenic yeast, which particularly infects immuno-compromised patients such as AIDS and organ transplant patients [1, 2] . There is considerable interest to understand the mechanisms of regulation of growth and morphogenesis of this yeast, which is a¡ected by several factors including carbon sources [2, 3] . There is evidence to suggest that C. albicans accumulates a number of sugars, such as L-sorbose, D-xylose, D-and L-arabinose, against concentration gradients [4, 3] . However, unlike other yeasts, work on sugar transport and transporters of C. albicans is still at an incipient stage and an in-depth investigation is required to gain insight into the mechanisms underlying transport of sugars.
The emergence of antifungal resistance in C. albicans has become a major threat to the usefulness of chemotherapy in treating the infection. To date several genes have been identi¢ed whose expression is linked to azole resistance [5^7] . How these genes are regulated is being vigorously pursued, and transcription factors like FCR (£uconazole resistance) 1,2,3 and CAP1 (C. albicans AP-1) regulating MDR genes of C. albicans have been identi¢ed [8] . The well studied yeast, Saccharomyces cerevisiae, whose genome is completely sequenced, revealed several genes involved in pleiotropic drug resistance (PDR) along with several transcription factors which regulate their expression [9, 10] . Interestingly, two putative sugar transporters, i.e. HXT9 and HXT11, are regulated by transcription factors, PDR1 and PDR3, which are known to regulate PDR genes of S. cerevisiae [11] . The facilitative glucose transporter GLUT1 has also been shown to be involved in the development of drug resistance in mammalian cells [12] . This paper describes the molecular cloning of the ¢rst glucose transporter gene, CaHGT1 (Candida albicans higha¤nity glucose transporter) of C. albicans. Using heterologous expression in S. cerevisiae mutant strain RE700A, the functionality of CaHGT1 is demonstrated. It encodes a high-a¤nity glucose transporter. In addition, an enhancement of CaHGT1 transcript is shown in response to the human steroid hormone progesterone and drugs. The results suggest that CaHGT1, which encodes a major facilitator superfamily (MFS) protein, could be linked to the drug resistance phenomenon in C. albicans.
Materials and methods

Strains and media
C. albicans ATCC 10261 was grown on YEPD medium (2% Bacto peptone, 1% yeast extract and 2% D-glucose). The glucose transport-de¢cient mutant of S. cerevisiae RE700A (MATa ura3-52 hxt1v: :HIS3: :vhxt4 hxt5: : LEU2 hxt2v: :HIS3 hxt3v: :LEU2 : :vhxt6 hxt7: :HIS3) [13] was maintained on YEP medium containing 2% maltose. RE700A was transformed with the expression vector pYEX-BX containing CaHGT1 downstream of the CUP1 promoter. The transformant was selected on minimal YNB medium consisting of 0.67% yeast nitrogen base and 2% carbon source (maltose or D-glucose) supplemented with appropriate amino acids without uracil. Plasmid pYEX-BX was induced by adding 0.5 mM copper sulfate. Transformation of S. cerevisiae RE700A and plasmid recovery from the transformants was carried out as described elsewhere [14] .
PCR and DIG labeling
CaHGT1 was cloned by amplifying C. albicans genomic DNA through PCR using primers: forward primer : 5P-ATGATGTTAGGTTTTGATATTTCTTCAATG-3P, reverse primer : 5P-CCCAATAATCAATTGAGCACGATT-TTGAAC-3P, designed from an unpublished partial sequence of the putative C. albicans sugar transporter (http://www.alces.med.umn.edu). The PCR product (260 bp) was ligated as a blunt-end fragment (Sure Clone Ligation Kit, Pharmacia, Freiburg, Germany) to SmaIdigested pUC18 (Pharmacia). This was sequenced and used as a probe for Southern hybridisation. All the probes used in the Southern blotting were labeled with digoxigenin-11-dUTP (DIG) using the random primer method with the DIG DNA Labeling kit from Boehringer Mannheim.
Subcloning and sequencing
Genomic DNA HindIII fragments were ligated to HindIII-digested pUC18 and HincII fragments from the fosmids were ligated to SmaI-digested pUC18. The constructs were used to transform Escherichia coli XL1 Blue cells. Plasmids recovered from the resulting transformed colonies were screened by the method of Southern hybridisation. Subclones were made using the restriction enzyme sites delineated by restriction mapping. These positive subclones were sequenced by the dideoxy chain termination method using double-stranded plasmid DNA as template [15] .
A BamHI site was placed upstream of the putative CaHGT1 ATG start codon (5P-ATAATCTCAAGGATC-CATGTCGTCCAA) and a PstI site was placed downstream of the stop codon UAA (3P-CCTAAATGGAATT-TAGCTGCAGCTTCAATTCTTCA) by PCR ampli¢ca-tion of the clone pAV-CaHGT1 containing the full ORF of CaHGT1. The resulting PCR product was doubledigested with BamHI and PstI and then ligated to the yeast expression vector pYEX-BX double-digested with BamHI and PstI downstream of the CUP1 promoter.
RNA extraction and Northern blotting
Total RNA isolation from C. albicans cells and Northern analyses were as described earlier [5] .
Glucose uptake and accumulation assays
The cells were grown to mid-exponential phase (15^16 h), harvested, washed with distilled water and incubated at 30³C for 2 h in fresh medium containing 0.1% D-glucose. Consumption of D-glucose from the medium was assayed enzymatically as described by Bergmeyer [16] .
Nucleotide sequence accession number
The CaHGT1 nucleotide sequence has been assigned GenBank accession number Y16834.
Results and discussion
Isolation of the C. albicans CaHGT1 Gene
A partial unpublished DNA sequence (http://www.alces.med.umn.edu) of a putative glucose transporter HGT1 of C. albicans was used to design two oligonucleotide primers. Under conditions of high stringency, these primers were used for PCR ampli¢cation with C. albicans ATCC 10261 genomic DNA. The puri¢ed PCR product of expected size (260 bp) was cloned into the pUC18 vector. Two positive clones were sequenced and found to be identical, both displayed 85% sequence identity with the high- a¤nity glucose transporter HGT1 of Kluyveromyces lactis.
The insert from one of these clones was used as a probe for genomic DNA Southern hybridisation. A V3-kb positive band was cloned in pUC18 (pAV1) and used for further characterisation. DNA sequence analysis of pAV1 revealed an incomplete ORF in the cloned 3-kb insert with homology to HGT1 of K. lactis and hexose transporter genes (HXTs) of S. cerevisiae [17, 18] and was found to be localised on chromosome I. In order to clone the complete ORF, the corresponding fosmid library of C. albicans [19] , containing chromosome I fragments, was screened using the 1-kb EcoRI-HindIII subfragment of pAV1 (pAV4, Fig. 1A ) as a probe. Southern analysis gave two positive bands of 4.2 kb and 2 kb from fosmids 11D6 and 18B4. The 4.2-kb HincII fragment was further subcloned into pUC18 at the SmaI site (pAV2) (Fig. 1A) . DNA sequence analysis of pAV2 revealed that pAV1 and pAV2 had 100% identity in the overlapping region (Fig. 1A) . In order to reconstruct the full ORF, the EcoRV-KpnI fragment of pAV1 was ligated to pAV2 digested with EcoRV-KpnI (KpnI of MCS of pUC18) resulting in pAV-CaHGT1 which, on sequence analysis, revealed a complete ORF comprising 545 amino acids (Fig. 1B) . The protein has a predicted molecular mass of 60.67 kDa.
Sequence analysis of the CaHGT1 gene
Substantial sequence similarity was observed between the cloned ORF and the members of glucose transporter families of S. cerevisiae and Schizosaccharomyces pombe [17, 18] . The greatest similarity (51% identity) was observed with HGT1, a high-a¤nity glucose transporter of K. lactis and hence the gene was designated CaHGT1. Hydrophobicity values determined at each residue by the method of Eisenberg et al. using a window size of 15 residues [20] showed the presence of 12 putative transmembrane (TM) domains (Fig. 1C) , a characteristic feature of the major facilitator superfamily [21] . The alignment of amino acid sequences of CaHGT1 (accession number Y16834) of C. albicans with HGT1 (accession number U22525) of K. lactis; GHT1 (accession number X91218), GHT2 (accession number AF017180) and GHT3 (accession number AF051139) of S. pombe; HXT1 (accession number U00060) and HXT2 (accession number M33270) of S. cerevisiae; GLUT1 (accession number S80434), GLUT2 (accession number L09674) and GLUT3 (accession number M20681) of Homo sapiens and SNF3 (accession number J03246) glucose sensor of S. cerevisiae [24] , generated using the CLUSTALW program (data not shown), revealed a conserved signature (IDKVGRRPLLIGG) typical of sugar facilitators (MFS) [21] . The sequence similarities among glucose transporters from yeast to human justify a close relationship of CaHgt1p with the high-af¢nity glucose transporter Hgt1p of K. lactis. In a dendrogram (data not shown), CaHGT1 and HGT1 of K. lactis form a distinct family of transporters which is less related to the group of Hxtp of S. cerevisiae than to the cluster of hexose transporters represented by Ghtp members of S. pombe [23, 24] Nucleotide sequence analysis revealed the presence of TATA-like motif at position 3107 with correlated CAP signal, as assessed using the EUKPROM algorithm (PC Gene, IntelliGenetics). The 5P upstream region of the initiation codon was found to be A+T-rich and harbouring a number of regulatory elements. Most striking was the presence of a putative progesterone/glucocorticoid response element (PRE, GRE: AGAACA) at 3718 and a putative estrogen response element (ERE : TGACAT) at 3453 with respect to ATG [22] . A putative pheromone response element (PhRE: TGTAAAAA) was also found at position 3991. The putative elements of PDR1 and PDR3, which are present in HXT9 and HXT11 of S. cerevisiae, were absent in CaHGT1 promoter.
CaHGT1 could complement the glucose transport defect when expressed in S. cerevisiae
In order to check the functionality of the cloned putative glucose transporter, the glucose uptake-de¢cient strain RE700A of S. cerevisiae, which is devoid of HXT1, 2, 3, 4, 5, 6 and 7 [13] , was used for heterologous expression of the CaHGT1 gene. The CaHGT1 ORF was placed under the copper-inducible promoter (CUP1) in the expression vector pYEX-BX with URA3 as the auxotrophic selectable marker. The expression construct pYEX-CaHGT1 was used to transform RE700A, yielding several colonies on medium containing 2% maltose without uracil. These colonies were then tested for growth on glucose. The transformants showed growth on glucose while RE700A and its transformant containing empty vector pYEX-BX did not show any growth on glucose ( Fig. 2A) . In order to con¢rm that the phenotype was plasmid-based, one of the transformants, AVY701, was grown under non-selective conditions (2% maltose+uracil) for several generations and then plated onto glucose-containing medium without uracil where several colonies failed to grow (data not shown). This con¢rmed that the growth of AVY701 on glucose was conferred by the plasmid pYEX-CaHGT1.
The glucose transport and speci¢city were determined enzymatically by following its consumption from the medium (Fig. 2B) . A steady consumption of glucose was demonstrated by the transformant AVY701 which was comparable even in the presence of a threefold excess of D-galactose. This con¢rmed that the observed D-glucose consumption was mediated by a speci¢c heterologously expressed C. albicans glucose transporter, CaHgt1p. The apparent K T value in the range of 1 mM was obtained from a Lineweaver-Burk plot (data not shown). Based on K T values of other hexose transporters [25, 26] , it would mean that the CaHGT1 gene product encodes a high-af¢nity glucose transporter.
CaHGT1 expression can be induced by progesterone and drugs
Northern blot analysis revealed that C. albicans cells incubated with 1 mM progesterone for 15 min exhibited enhanced expression of CaHGT1 (Fig. 3A, lane 3) as compared to the control (lane 1). L-Oestradiol, on the other hand, did not a¡ect the expression of CaHGT1 (lane 2). Interestingly, when C. albicans cells were preincubated with di¡erent drugs, viz. benomyl, chloramphenicol, cycloheximide, miconazole and 4-nitroquinoline-N-oxide, the expression of CaHGT1 was enhanced upon incubation with only cycloheximide, benomyl and chloramphenicol. In comparison, the increase in expression was maximal with cycloheximide (Fig. 3B) .
Earlier studies have suggested that the MFS protein and facilitative glucose transporter (Glut1p) of mammalian cells [12] could be involved in the development of drug resistance. Furthermore, HXT9 and HXT11 are regulated by transcription factors PDR1 and PDR3 which regulate the ABC transporters required for drug resistance in yeast. The induced expression of CaHGT1 by drugs would suggest commonality among these MFS proteins. Whether CaHgt1p and several other putative glucose transporters of C. albicans (http://www.alces.med.umn.edu) are also regulated by ABC regulators remains to be established. It is tempting to speculate that the study of sugar transporter genes and their regulation would lead to a better understanding of the regulation of drug susceptibilities of C. albicans.
Mammalian steroid hormones from the microenvironment have been found to a¡ect the growth and morphogenesis of the invading C. albicans [27] . In addition, oestrogen binding proteins (EBP) have been identi¢ed in C. albicans [28] which binds oestrogen with high a¤nity, stimulating the transition from yeast to the mycelial form [27] . The interaction of some of the azoles, such as ketoconazole, with the corticosteroid receptor and binding protein has also been suggested. We have earlier reported that human steroid hormones can up-regulate the expression of an ABC transporter, CDR1 (Candida drug resistance) [5, 14] . In this study we further show that progesterone can also transcriptionally activate the expression of the MFS transporter CaHGT1. The mechanism underlying steroid-mediated gene regulation in yeast is not clear. It is worth pointing out that steroid response elements do exist in Candida genes (http://www.alces.med.umn.edu), though unlike their mammalian counterparts, they do not exist as The transformed strain AVY701 was grown in YNB medium containing 2% glucose without uracil; RE700A containing empty vector was grown in YNB containing 2% maltose without uracil; and RE700A was grown in YNB containing 2% maltose with uracil. After harvesting, the cells were washed with YNB and transferred to fresh YNB for 2 h. The enzymatic assay for D-glucose consumption was done as described by Bergmeyer [16] .
palindromic repeats but only as one half of one. This, however, could suggest that Candida may harbour a unique steroid receptor cascade which remains unidenti¢ed. This aspect of gene regulation, mediated by human steroid hormones in C. albicans, is under investigation. 
